Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USA

OBJECTIVES: Effective oral therapies for hepatitis B and C have recently been developed, while there are no approved pharmacological therapies for alcoholic and non-alcoholic fatty liver diseases (ALD and NAFLD). We hypothesise that fewer advances in fatty liver diseases could be related to disparit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndugga, Nambi, Lightbourne, Teisha G, Javaherian, Kavon, Cabezas, Joaquin, Verma, Neha, Barritt, A Sidney, Bataller, Ramon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372160/
https://www.ncbi.nlm.nih.gov/pubmed/28336739
http://dx.doi.org/10.1136/bmjopen-2016-013620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372160/
https://www.ncbi.nlm.nih.gov/pubmed/28336739
http://dx.doi.org/10.1136/bmjopen-2016-013620

Ejemplares similares